PHASE-II CLINICAL-STUDY OF HIGH-DOSE TOREMIFENE IN PATIENTS WITH ADVANCED BREAST-CANCER

被引：8
|
作者：
MODIG, H
BORGSTROM, S
NILSSON, I
WESTMAN, G
机构：
[1] MALMO GEN HOSP,DEPT ONCOL,S-21401 MALMO,SWEDEN
[2] OREBRO REG HOSP,DEPT ONCOL,OREBRO,SWEDEN
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90015-K
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thirteen postmenopausal women with advanced local or metastatic breast cancer were treated with the antiestrogen toremifene at a daily dose of 200 mg. All patients had failed previous treatment with different types of endocrine therapy and/or cytotoxic drugs. Objective response was only seen in one patient. Treatment was usually well tolerated but in three cases the drug had to be withdrawn due to side effects. © 1990.
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [21] PHASE-II STUDY OF ELLIPTINIUM IN ADVANCED BREAST-CANCER
    ROUESSE, JG
    LECHEVALIER, T
    CAILLE, P
    MONDESIR, JM
    SANCHOGARNIER, H
    MAYLEVIN, F
    SPIELMANN, M
    DEJAGER, R
    AMIEL, JL
    CANCER TREATMENT REPORTS, 1985, 69 (06): : 707 - 708
  • [22] A PHASE-II STUDY OF MITOXANTRONE IN ADVANCED BREAST-CANCER
    THOMPSON, PI
    HARVEY, VJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (03): : 142 - 142
  • [23] PHASE-II STUDY OF SPIROGERMANIUM IN ADVANCED BREAST-CANCER
    KUEBLER, JP
    TORMEY, DC
    HARPER, GR
    CHANG, YC
    KHANDEKAR, JD
    FALKSON, G
    CANCER TREATMENT REPORTS, 1984, 68 (12): : 1515 - 1516
  • [24] MITOXANTRONE, A PHASE-II STUDY IN ADVANCED BREAST-CANCER
    COLEMAN, RE
    MAISEY, MN
    KNIGHT, RK
    RUBENS, RD
    BRITISH JOURNAL OF CANCER, 1984, 49 (03) : 390 - 390
  • [25] PHASE-II STUDY OF MAYTANSINE IN ADVANCED BREAST-CANCER
    EDMONSON, JH
    RUBIN, J
    KVOLS, LK
    OCONNELL, MJ
    FRYTAK, S
    GREEN, SJ
    CANCER TREATMENT REPORTS, 1981, 65 (5-6): : 536 - 537
  • [26] PHASE-II STUDY OF NAVELBINE IN ADVANCED BREAST-CANCER
    CANOBBIO, L
    BOCCARDO, F
    PASTORINO, G
    BREMA, F
    MARTINI, C
    RESASCO, M
    SANTI, L
    SEMINARS IN ONCOLOGY, 1989, 16 (02) : 33 - 36
  • [27] PHASE-II STUDY OF ORAL ETOPOSIDE FOR PATIENTS WITH ADVANCED BREAST-CANCER
    ATIENZA, DM
    VOGEL, CL
    TROCK, B
    SWAIN, SM
    CANCER, 1995, 76 (12) : 2485 - 2490
  • [28] A PHASE-II STUDY OF MITOZANTRONE IN ADVANCED BREAST-CANCER
    THOMPSON, PI
    HARVEY, VJ
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 268 - 268
  • [29] PHASE-II STUDY OF AMONAFIDE IN ADVANCED BREAST-CANCER
    SCHEITHAUER, W
    DITTRICH, C
    KORNEK, G
    HAIDER, K
    LINKESCH, W
    GISSLINGER, H
    DEPISCH, D
    BREAST CANCER RESEARCH AND TREATMENT, 1991, 20 (01) : 63 - 67
  • [30] PHASE-II STUDY OF TCNU IN ADVANCED BREAST-CANCER
    DOMBERNOWSKY, P
    CLAVEL, M
    SMYTH, JF
    HOWELL, A
    VANGLABEKKE, M
    RENARD, J
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (08): : 1377 - 1378
12345